We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cardiac Tumors in Children

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00215085
Recruitment Status : Terminated (insufficient data)
First Posted : September 22, 2005
Last Update Posted : March 16, 2012
Sponsor:
Information provided by:

Study Description
Brief Summary:
The purpose of this study is to define the natural history of untreated cardiac tumors, study the pathology of primary cardiac tumors, review the surgical treatment and results of primary cardiac tumors and to determine the prognosis for these tumors.

Condition or disease
Congenital Heart Disease

Detailed Description:

Primary cardiac tumors in children are extremely rare. Benign tumors are typically myxomas, lipomas, and rhabdomyomas, while malignant tumors are typically angiosarcomas and rhabdomyosarcomas. Due to the rarity of these tumors, it is difficult to gather meaningful information regarding their natural history, pathology and treatment.

The primary aims are to define the natural history of untreated cardiac tumors, study the pathology of primary cardiac tumors, review the surgical treatment and results of primary cardiac tumors and to determine the prognosis for these tumors. The secondary aims are to discover patterns and consistencies among primary cardiac tumors and to define the best treatment options for these patients. The study will be conducted through a retrospective chart review of about 70 patients.


Study Design

Study Type : Observational
Estimated Enrollment : 70 participants
Time Perspective: Retrospective
Official Title: Cardiac Tumors in Children
Study Start Date : May 2005
Study Completion Date : November 2006

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients in the congenital surgery database

  • Children who have been treated for a primary cardiac tumor
Criteria

Inclusion Criteria:

  • Patients in the congenital surgery database
  • Children who have been treated for a primary cardiac tumor
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00215085


Locations
United States, Georgia
Children's Healthcare of Atlanta
Atlanta, Georgia, United States, 30322
Sponsors and Collaborators
Children's Healthcare of Atlanta
Investigators
Principal Investigator: Brian Kogon, MD Emory University
More Information

ClinicalTrials.gov Identifier: NCT00215085     History of Changes
Other Study ID Numbers: 05-091
First Posted: September 22, 2005    Key Record Dates
Last Update Posted: March 16, 2012
Last Verified: May 2007

Keywords provided by Children's Healthcare of Atlanta:
pediatric health
cardiac
cardiac tumor
children

Additional relevant MeSH terms:
Heart Diseases
Heart Neoplasms
Cardiovascular Diseases
Thoracic Neoplasms
Neoplasms by Site
Neoplasms